TransMedics Group is trading 4.09% up at $94.57 as healthcare stocks rally alongside broader risk-on sentiment.
- No clear company-specific announcement emerged on August 21, 2026.
- Recent earnings showed strong revenue growth and raised guidance; results were released August 4.
- Shareholder-investigation notices appeared earlier this week, while gains in major U.S. indexes and enthusiasm around cancer-vaccine developments supported sector momentum.